Immudex产品代理
Immudex产品代理
我们授权全球的研究人员和临床医生通过先进的基于抗原特异性免疫的工具推动医学的发展。
Immudex 成立于 2009 年，当时它从诊断公司 Dako（现为安捷伦）分拆出来。从那时起，Immudex 在数量、员工、专利、产品线、合作伙伴和服务的客户方面都有所增长。
研究、开发和商业活动总部位于丹麦哥本哈根，自 2010 年起在弗吉尼亚州费尔法克斯开展业务。
不仅仅是一家公司。一个原因。
Immudex 的基础不是产品。相反，可以肯定的是，对免疫系统的详细了解可以扩大医学界限并开辟新的治疗和诊断机会。
免疫系统及其细胞反应非常复杂，借助正确的研究和诊断工具，我们可以解开这种复杂性。我们愿景的核心是希望为全世界的研究人员和临床医生提供帮助，帮助他们开发更有效的基于免疫的疗法和诊断方法。
Your Trusted Partner in Cellular Immune Monitoring
We empower researchers and clinicians worldwide to push the boundaries of medicine through advanced antigen-specific immune-based tools.
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served.
Research, development, and commercial activities are headquartered in Copenhagen, Denmark, with operations in North America since 2010 out of Fairfax, Virginia.
More Than a Company. A Cause.
The foundation of Immudex is not a product. Instead, it is the certainty that a detailed understanding of the immune system can expand medicine boundaries and open new therapeutic and diagnostic opportunities.
The immune system and its cellular response are highly complex, and with the right research and diagnostic tools, we can unravel that complexity. At the core of our vision is the desire to be there for researchers and clinicians worldwide, helping them develop more effective immune-based therapeutics and diagnostics.
